Cytosorbents Crp (CTSO)vsGE HealthCare Technologies Inc. (GEHC)
CTSO
Cytosorbents Crp
$0.39
-5.94%
HEALTHCARE · Cap: $22.75M
GEHC
GE HealthCare Technologies Inc.
$65.57
+1.35%
HEALTHCARE · Cap: $29.51B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 56295% more annual revenue ($20.98B vs $37.20M). GEHC leads profitability with a 9.1% profit margin vs -31.9%. GEHC earns a higher WallStSmart Score of 57/100 (C).
CTSO
Avoid24
out of 100
Grade: F
GEHC
Buy57
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
Trading at 9.8x book value
1.6% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Expensive relative to growth rate
Weak financial health signals
Earnings declined 30.9%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : CTSO
CTSO has a balanced fundamental profile.
Bull Case : GEHC
The strongest argument for GEHC centers on P/E Ratio, Price/Book.
Bear Case : CTSO
The primary concerns for CTSO are Price/Book, Revenue Growth, EPS Growth. Debt-to-equity of 8.64 is elevated, increasing financial risk.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
CTSO profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.
CTSO carries more volatility with a beta of 1.36 — expect wider price swings.
GEHC is growing revenue faster at 7.4% — sustainability is the question.
GEHC generates stronger free cash flow (112M), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (57/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cytosorbents Crp
HEALTHCARE · MEDICAL DEVICES · USA
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?